Glioma klinikiniai tyrimai Alabama
6 tyrimai dėl Glioma ieško dalyvių vietose Alabama.
Miestai Alabama
Oficialus tyrimo tekstas (anglų kalba)
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
- Children's Hospital of Alabama, Birmingham
Renkami dalyviai1/2 fazė
12 Months – 21 Years · Visoms lytims · Atnaujinta 2026-10-01 · NCT05099003Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
- University of Alabama at Birmingham O'Neal Comprehensive Cancer Center, Birmingham
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-28 · NCT07326566HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
- University of Alabama at Birmingham Cancer Center, Birmingham
Renkami dalyviai1 fazė
36 Months – 22 Years · Visoms lytims · Atnaujinta 2026-09-04 · NCT03911388SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
- University of Alabama, Birmingham
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-28 · NCT05303519Multiparametic Metabolic and Hypoxic PET/MRI for Disease Assessment in High Grade Glioma
- UAB, Birmingham
- UAB, Birmingham
Renkami dalyviaiAnkstyvoji 1 fazė
Amžius nuo 10 iki 89 · Visoms lytims · Atnaujinta 2026-08-20 · NCT05632562Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021)
- University of Alabama at Birmingham, Children's of Alabama, Birmingham
Renkami dalyviai1 fazė
Amžius nuo 1 iki 25 · Visoms lytims · Atnaujinta 2026-08-18 · NCT04485559Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.